Drug candidate: EI-1071

Inventor: Hung-Kai Chen, MD, PhD.

Collaborator: Elixiron Immunotherapeutics Inc., Taiwan

Types: Small molecule (inhibitor)

Target: CSF-1R

Indication: Alzheimer's disease

Administration route: Oral

• 2022 Part the Cloud-Gates Partnership Grant Program

Issuer: Alzheimer’s Association and Bill Gates

Funding: 800,000 USD

• 2020 Part the Cloud-Gates Partnership Grant Program

Issuer: Alzheimer’s Association and Bill Gates

Funding: 1,000,000 USD